Accelerated Assessment Decision ‘Imminent’ For Two Products In EMA’s PRIME Scheme

 
• By Neena Brizmohun

The sponsors of two products in the European Medicines Agency’s popular PRIME scheme for speeding patient access to drugs for unmet medical needs appear to be close to filing their applications for marketing authorization. Five more products were accepted on the scheme this week.

airport runway under the sun as background
The EMA's PRIME scheme should speed time to market • Source: Shuttestock

More from Europe

More from Geography